IP Library › Assignment 064277/0514
Patent Assignment
Reel/Frame 064277/0514

Assignment of Assignor's Interest

Recorded: 2023-07-17 Pages: 6
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Indazolyl Derivatives Useful as Potassium Channel Modulating Agents
Patent: 8,222,262 →
Application: 12/444,344 →
Publication: US 2009/0325989
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 1, 2009
From: ERIKSEN, BIRGITTE L.; SORENSEN, ULRIK SVANE; HOUGAARD, CHARLOTTE; TEUBER, LENE
To: NEUROSEARCH A/S
Reel/Frame 022904/0533 →
Assignment of Assignor's Interest Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
Assignment of Assignor's Interest Aug 6, 2013
From: ANIONA APS
To: ATAXION, INC.
Reel/Frame 030946/0329 →
Merger Jul 17, 2023
From: ATAXION, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 064277/0494 →
Change of Name Jul 17, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 064277/0542 →